CHAPTER 6 Secondary prevention of cervical cancer

International Journal of Gynecology and Obstetrics

Volumn 94, Issue SUPPL. 1, 2006, Pages

  Denny, Lynette ^a   Sankaranarayanan, Rengaswamy ^a  

^a NONE

Author keywords

Cervical cancer; Prevention; Screen and treat; Visual inspection with acetic acid (VIA); Visual inspection with Lugol's iodine (VILI)

Indexed keywords

ACETIC ACID;

ARTICLE; CANCER CYTODIAGNOSIS; CANCER SCREENING; CAUSE OF DEATH; CONTROLLED STUDY; DEVELOPING COUNTRY; DIAGNOSTIC APPROACH ROUTE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LONGITUDINAL STUDY; PRIORITY JOURNAL; SCREENING TEST; SECONDARY PREVENTION; UTERINE CERVIX CANCER;

EID: 33846598419     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-7292(07)60012-5     Document Type: Article

References (24)

1. International Agency for Research on Cancer. Cervix Cancer Screening. IARC Handbooks on Cancer Prevention Volume 10 (2006), IARC Press, Lyon, France
2. Sankaranarayanan R., Budukh A., and Rajkumar R. Effective screening programs for cervical cancer in low- and middleincome developing countries. Bull World Health Organization 79 (2001) 954-962
3. Ferlay J., Bray F., Pisani P., and Parkin D. GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide (2004), IARC Press, Lyon, France IARC Cancer Base No. 5, Version 2.0
4. In: Sankaranarayanan R., Black R., and Parkin D. (Eds). Cancer Survival in Developing Countries (1988), IARC Press, Lyon, France IARC Scientific Publications No. 145.
5. In: Hakama M., Miller A., and Day Ne (Eds). Screening for cancer of the uterine cervix (1986), IARC Press, Lyon, France IARC Scientific Publication No. 76.
6. Laara E., Day N., and Hakama M. Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes. Lancet 1 8544 (1987) 1247-1249
7. IARC Working Group on Evaluation of Cervical Cancer Screening Programmes. Screening for squamous cervical cancer: the duration of low risk after negative result of cervical cytology and its implication for screening policies. BrMed J 293 (1986) 659-664
8. Alliance for Cervical Cancer Prevention (ACCP). Planning and Implementing Cervical Cancer Prevention and Control Programs: A Manual for Managers (2004), ACCP, Seattle, WA, USA
9. Fahey M., Irwig L., and Macaskill P. Meta-analysis of Pap test Accuracy. Am J Epidemiol 141 (1995) 680-689
10. Mitchell M., Schottenfeld D., Tortolera-Luna G., Cantor S., and Richards-Kortum R. Colposcopy for the diagnosis of squamous intraepithelial lesions: a meta-analysis. Obstet Gynecol 91 (1998) 626-631
11. Nanda K., McCrory D., Myers E., Bastian L., Hasselblad V., Hickey J., et al. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann intern Med 132 (2000) 810-819
12. Sankaranarayanan R., Gaffikin L., Jacob M., Sellors J., and Robles S. A critical assessment of screening methods for cervical neoplasia. Int J Gynaecol Obstet 89 suppl 2 (2005) S4-S12
13. Gage J., Ferreccio C., Gonzales M., Arroyo R., Huivin M., and Robles S. Folow-up care of women with an abnormal cytology in a low-resource setting. Cancer Detect Prev 27 (2003) 466-471
14. Sepulveda C., and Prado R. Effective cervical cytology screening programmes in middle-income countries: the Chilean experience. Cancer Detect Prev 29 (2005) 405-411
15. Sankaranarayanan R., and Wesley R. A practical manual on visual screening for cervical neoplasia (2003), IARC Press, Lyon, France IARC Technical Publication No. 41.
16. Blumenthal P., Lauterbach J., Sellors J., and Sankaranarayanan R. Training for Cervical Cancer Prevention Programs in Low-Resource Settings: Focus on visual inspection with acetic acid and cryotherapy. Int J Gynaecol Obstet 89 suppl 2 (2005) S4-S12
17. In: Mcintosh N., Blumenthal P., and Blouse A. (Eds). Cervical Cancer Prevention Guidelines for Low-Resource Settings (2001), JHPIEGO, Baltimore, Md, USA JHPIEGO Technical Manual.
18. Sankaranarayanan R., Rajkumar R., Theresa R., Esmy P., Mahe C., Bagyalakshmi K., et al. Initial results from a randomized trial of cervical visual screening in rural south India. Int J Cancer 109 (2004) 461-467
19. Sankaranarayanan R., Nene B., Dinshaw K., Mahe C., Jayant K., Shastri, et al. Osmanabad District Cervical Screening Study Group. A cluster randomised controlled trial of visual, cytology and HPV screening for cancer of the cervix in rural India. Int J Cancer 116 (2005) 617-623
20. Sankaranarayanan R., Basu P., Wesley R., Mahe C., Keita N., Gombe Mbalawa C., et al. IARC Multicentre Study Group on Cervical Cancer Early Detection. Accuracy of visual screening for cervical neoplasia: results from an IARC multicentre study in India and Africa. Int J Cancer 110 (2004) 907-913
21. Sarian L., Derchain S., Naud P., Rateli-Martins C., Longatto-Filho A., Tatti S., et al. Evaluation of visual inspection with acetic acid (VIA), Lugol's iodine (VILI), cervical cytology and HPV testing as cervical screening tools in Latin America. J Med Screen 12 (2005) 142-149
22. Royal Thai College of Obstetricians and Gynaecologists (RTCOG)/JHPIEGO Corporation Cervical Cancer Prevention Group. Safety, acceptability, and feasibility of a single-visit approach to cervical-cancer prevention in rural Thailand: a demonstration project. Lancet 61 (2003) 814-820
23. Denny L., Kuhn L., De Souza M., Pollack A., Dupree W., and Wright Jr. T. Screen-and-treat approaches for cervical cancer prevention in low-resource settings: a randomized controlled trial. JAMA 294 (2005) 2173-2181
24. Goldie S., Gaffikin L., Goldhaber-Fiebert J., Gordillo-Tobar A., Levin C., Mahe C., et al. Cost effectiveness of cervical screening in five developing countries. N Eng J Med 353 (2005) 2158-2168